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Abstract
Background: Human Rhinovirus (HRV) is responsible for the majority of common colds and is frequently
accompanied by secondary bacterial infections through poorly understood mechanisms. We investigated the
effects of experimental human HRV serotype 16 infection on the upper respiratory tract microbiota.
Methods: Six healthy volunteers were infected with HRV16. We performed 16S ribosomal RNA-targeted
pyrosequencing on throat swabs taken prior, during and after infection. We compared overall community diversity,
phylogenetic structure of the ecosystem and relative abundances of the different bacteria between time points.
Results: During acute infection strong trends towards increases in the relative abundances of Haemophilus
parainfluenzae and Neisseria subflava were observed, as well as a weaker trend towards increases of Staphylococcus
aureus. No major differences were observed between day-1 and day 60, whereas differences between subjects were
very high.
Conclusions: HRV16 infection is associated with the increase of three genera known to be associated with
secondary infections following HRV infections. The observed changes of upper respiratory tract microbiota could
help explain why HRV infection predisposes to bacterial otitis media, sinusitis and pneumonia.
Background
Human Rhinovirus is a globally endemic virus, belonging
to the family of Picornaviridae and the most common
cause of the common cold. Although usually causing
mild to moderate disease, HRV triggers exacerbations
of chronic obstructive pulmonary disease, asthma and
cystic fibrosis [1, 2], and may cause severe lower re-
spiratory tract disease particularly in risk groups such as
infants, the elderly and immunocompromised patients [3].
In addition, infection with HRV is a predisposing factor
for secondary bacterial infections (otitis media, sinusitis,
pneumonia) [4–7]. Insights into the mechanisms through
which HRV enhances bacterial supra-infection remain
limited.
HRV associated bacterial superinfections are assumed
to be caused in part by anatomical and mechanical
causes, e.g. due to Eustachian tube dysfunction [8],
ostiomeatal obstruction and reduced mucocilliary clear-
ance [9, 10]. In addition, HRV infection may increase
epithelial permeability [11], promote bacterial adherence
and entry into the epithelium [12, 13] or reduce host re-
sponses to bacterial pathogens[14]. Common pathogens
associated with HRV-associated bacterial infections in-
clude S. pneumoniae, H. influenzae and M. catarrhalis.
In recent years, culture-independent DNA-based tech-
niques demonstrated that highly complex microbial
communities are present in the upper airways. These
communities are an integral part of our commensal air-
way microbiota and likely contribute to infection and
disease. HRV infection and the subsequent host response
[11–14] change the upper airway local environment and
will likely alter the microbiota composition. Insights into
HRV induced changes in microbiota composition could
contribute to our understanding of the pathophysiological
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mechanisms of bacterial super-infection and could help to
predict secondary bacterial infections thereby ultimately
contributing to preventive strategies and tools. Most
human studies to date have been retrospective, showing
epidemiological correlations between HRV and the pres-
ence of potential respiratory pathogens [15–17]. Such cor-
relation, however, do not necessarily implicate causality
and interpretation of these data warrants caution. Most
studies of the lung microbiota have been cross-sectional,
observational and descriptive in nature [18].
Here we describe the effects of HRV infection on the
upper respiratory tract microbiota in otherwise healthy
human volunteers experimentally infected with HRV
serotype 16 (HRV16), enabling controlled observations
before, during and after resolution of infection. We hy-
pothesized that HRV16 infection alters throat bacterial
microbiota compositions in healthy volunteers in terms
of the bacterial diversity (Shannon and Simpson diversity
indexes) as well as bacterial richness (Chao1 measure).
We also analysed changes over time in relative abun-
dances of individual bacterial genera/species.
Methods
Study subjects
Healthy volunteers (6 in total) aged 18–60 were eligible
for participation provided they had not had a common
cold during the six weeks prior to enrolment.
Presence of common cold was defined as a cumulative
validated cold symptom score [19] of ≥ 14 over a 6 day
period and the subjective impression of a cold, rhinor-
rhoea on at least three days. Other exclusion criteria were:
receipt of BCG-vaccination, chest x-ray abnormalities, a
history of lung disease, signs of airway obstruction (Forced
Expiratory volume in 1 s (FEV1) > 80 % of predicted
value), seasonal or perennial rhinitis or sinusitis, smoking
(unless stopped smoking 12 months prior to the study,
max. 5 pack years), any clinically significant abnormality
in medical history and clinical examination, participation
in any clinical investigational drug treatment protocol
within 30 days of enrolment, pregnancy or lactation, any
medication usage. The study protocol was approved by
the Academic Medical Center Amsterdam ethical review
committee. Written informed consent was obtained from
all volunteers.
Study design
In this prospective single center study all volunteers
were experimentally infected with HRV16 (Fig. 1). Upon
enrolment the volunteers were screened to ensure the
absence of circulating antibodies against tuberculosis,
HRV16, Human T-lymphotropic virus Type 1 (HTLV-1)
and 2 (HTLV-2), Human Immunodeficiency virus (HIV),
and Hepatitis A, B and C virus (HAV, HBV, HCV).
Acute infection with Influenza A and B, enterovirus sp.,
adenovirus sp., rhinovirus sp., human metapneumovirus,
human respiratory syncytial virus sp., parainfluenza vi-
ruses 1-4, human parechovirus, human bocavirus,
coronavirus sp., Chlamydia pneumoniae, Mycoplasma
pneumoniae, legionella sp. was excluded through val-
idated PCR assays on nasal lavage and throat swabs.
These throat swabs were collected to serve as base-
line microbiota measures. One day later volunteers
were experimentally infected with HRV16 (details
below), which has been shown to cause mild
common-cold symptoms. Nasal lavages and throat
swabs were performed daily for 7 days. On day 60 a
convalescent throat swab was taken. All volunteers
were requested to report common cold and asthma
symptoms daily until day 7 after rhinovirus challenge
using a standardized cold symptom score [20]. Diar-
ies were collected at the final visit.
HRV16 challenge
Experimental HRV16 infection was induced as described
previously [21]. In short, 100 μl of an HRV16 aliquot
(stored at -80 °C) was kept on ice, thawed and diluted in
sterile 0.9 % NaCl just before exposure. 750 μl of this di-
lution was transferred to a sterile micronic tube posi-
tioned in a glass support of the DeVilbiss 286 atomizer
(DeVilbiss Healthcare, Somerset, PA, USA). This dilution
was administered to the healthy volunteer by spray in
one nostril while closing off the other nostril. The total
administered HRV16 dose was 10TCID50. Infection was
confirmed by positive PCRs, positive viral cultures and
development of symptoms.
Nasal lavage
One nostril was closed off using an inflatable catheter as
described previously [20].
Slowly, 10 ml of sterile Hanks balanced salt solution
(without phenol) at body temperature was instilled via
the catheter and left for 5 min. Lavage fluid was col-
lected in tube for viral detection. The procedure was re-
peated in the other nostril. All used materials were
sterile or disinfected using 70 % ethanol prior to use.
Throat swabs
A cotton-tipped swab (Copan Diagnostics, Corona, Canada)
was used to obtain material from the space between the
palatine arches. The cotton swab was transferred to
universal transport medium (UTM, Copan Diagnostics)
in a tightly closed tube. After vortexing, the swab was
discarded and the medium was stored at -80 °C.
Infection was confirmed by HRV-positive quantitative
PCR in nasal and/or throat samples as described else-
where [19]. In addition, presence of replication-competent
HRV was confirmed by virus culture (human embryonic
lung cells).
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16S rRNA gene analysis
After treatment with an in-house enzymatic cocktail
(achromopeptidase, mutanolysine, lysostaphine (1000:100:3)
and lysosyme (1 mg/ml) (Sigma-Aldrich, St. Louis, MO,
USA) in TE-buffer) as well as an in-house lysis buffer
(Sodium-docecyl-Sulphate (1 %), Tween-20 (0.5 %) and
Sarkosyl (0.5 %) in TE-buffer), DNA was extracted
using the MagnaPure LC (Roche Diagnostics, Indian-
apolis, IN, USA) following the manufacturer’s instruc-
tions. Bacterial rRNA genes were quantified by rt-PCR
using primers F-16S-27 (5′-AGAGTTTGATCCTGGCTCA
G-3′) and R-16S-355 (5′- GCTGCCTCCCGTAGGAGT-3′)
which bind to an area of the 16S rRNA gene con-
served in all bacteria [26, 27], and probe P-16S
(6FAM-CTGGCGGCRKGCYTAACACATGCAAGTCGA-
BHQ1). Subsequently, 16S rRNA genes were amplified
using the primers detailed in the supplementary material
followed by a second round of PCR using primers with
adapters and barcodes (see Additional file 1 for full
description).
The amplified fragments with adapters and tags were
quantified using the Quant-iT dsDNA Assay Kit on a Qubit
fluorometer (Invitrogen/Life Technologies, Carlsbad, CA,
USA). Emulsion PCR was performed according to the
protocol (emPCR Method Manual – Lib-A SV jan-
2010) supplied with the GS FLX Titanium XLR 70 Se-
quencing kit (Roche Diagnostics, Indianapolis, IN,
USA). Two- region 454 sequencing run was performed
on a GS FLX Titanium Pico TiterPlate (70 × 75) using
a GS FLX Titanium Sequencing Kit XLR70 according
to the manufacturer’s instructions (Roche Diagnostics,
Indianapolis, IN, USA).
Data processing and analysis
Data analysis was performed using the software “Quantita-
tive Insights into Microbial Ecology” (QIIME 1.8.0) [22].
After removal of low quality reads (quality score <25) and
chimera (ChimeraSlayer) our data was denoised using the
QIIME denoiser program [23]. Then we clustered the se-
quences into Operational Taxonomical Units (OTU’s)
based on 97 % sequence similarity (Uclust) [24]. The
resulting OTU table was then condensed by removing all
OTUs representing less than 0.005 % of the total number
of sequences [25]. Uclust classifier was used to assign tax-
onomy. FastTree was used to construct a phylogenetic
tree for downstream analyses.
Community structure
Bacterial taxonomic richness and diversity were deter-
mined using rarefaction plots of the normalized number
of sequences per time point. Rarefaction curves were
generated for 3 % genetic difference level (e.g. at the
genus level). The Shannon diversity measure is a quanti-
tative measure that reflects the number of different spe-
cies simultaneously taking into account how evenly the
bacteria are distributed among those species [26]. An-
other method to examine the microbiota community
structure is to use the Chao1 measure which estimates
the minimum richness in each sample [27]. Chao1, by
taking into account the number of species found only
once (singletons) or twice (doubletons) in a sample, pro-
vides an estimation of the number of undetected species
in the microbiota, which is important as the human as-
sociated microbiota contains many rare species.
UniFrac is a method to calculate a distance measure be-
tween samples using the phylogenetic trees. The UniFrac
measure expresses the fraction of shared branches in the
phylogenetic trees between samples [28].
Ecological intra- and inter-patient microbiota similar-
ity was estimated using adonis, ANOSIM and MRPP
methods included in QIIME 1.8.0. Briefly, these methods
compare the ecological distance between samples
(Unifrac distance) to test the null hypothesis that intra-
group similarity is not significantly different than inter-
group similarity [29].
Statistical analysis
With a sample size (n = 6) we expected to be able to de-
tect an effect of 25 % on the bacterial richness measure
Chao1 with two-sided significance of p = 0.05 and a power
of 90 %, assuming a standard deviation of 20 %. We nor-
malized the data by calculating the OTU proportion—the
Fig. 1 Study design. Screening was performed on the day before experimental rhinovirus infections. Nasal washes and throat swabs for Human
Rhinovirus (HRV) PCR and viral culturing were repeated daily from day 0 until day 7. A throat swab for 16S rRNA gene sequencing was collected
prior to HRV16 challenge (day -1) and subsequently on days 2, 5, and day 60
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proportion of total sequences per microbial community,
i.e., per sample. To compare differences in microbiota
members between time points we used a linear mixed
model. Microbial community comparisons were performed
using parametric statistics in R, with the P values corrected
by multiple hypothesis testing using the false discovery rate
(FDR) [30]. To assess differences in overall community
structure the data of all volunteers were pooled per time
point and diversity measures (alpha diversity measures
Shannon index, Simpson index and Chao1) [28]. Consider-
ing that the alpha diversity indices (i.e. Shannon diversity
and Chao1) are sensitive to the original number of se-
quences generated from a given sample [31] we calculated
the Shannon and Simpson diversity and Chao1 for normal-
ized numbers of sequences for each separate sample. A
number of randomly picked reads, corresponding to the
lowest number of sequences in a sample group was picked
100 times from each sequence set.
Results
Clinical data
In total 6 volunteers (3 males, 3 females) were included
in the study (age range 18-28 years). HRV16 infection
was established as demonstrated by positive HRV PCRs,
positive viral cultures (data not shown) and development
of symptoms in all. Viral RNA loads of nasal washes and
throat swabs and the cold symptom scores are shown
in Fig. 2.
16S analysis results
After removing sequences representing less than 0.005 %
of the total abundance, the median number of sequences
per sample was 5407 (min.: 2760; max.: 8589; sd: 1283.3).
When sequences were clustered at 97 % sequence identity
384 operational taxonomical units (OTUs) were identified.
Taxonomic analysis identified 11 bacterial phyla, contain-
ing 80 genera, 53 of which were successfully identified
with >80 % confidence. The most commonly amplified
bacterial phyla (Proteobacteria, Bacteroidetes, Actinobac-
teria, and Firmicutes) did not vary significantly over time
(Fig. 3). Streptococcus, Prevotella, Veillonella, Rothia, and
Haemophilus were the 5 most common bacterial genera
amplified, together accounting for 63.8 % of the total
number of sequences. These genera contained 101 species
level OTUs, 20 of which were successfully identified
(>90 % sequence similarity).
Community structure
Alpha diversity measures (Chao1, Shannon and Simpson
indexes) were similar in specimens obtained at baseline
or convalescence (days -1 and 60) and during infection
(days 2 and 5).
A principle coordinates analysis based on the weighted
UniFrac measure (fraction of shared branches in a
phylogenetic tree) revealed that samples seem to cluster
by individual volunteer although there was substantial
overlap between individuals (Fig. 4). All 3 measures of
ecological clustering (Adonis, ANOSIM and MRPP)
showed that intra-individual UniFrac distance between
samples was lower than inter-individual sample distance.
Analysis on the data pooled by time point based on the
UniFrac measure revealed no significant differences be-
tween time points (weighted UniFrac significance p >
0.05, data not shown) nor were time points 2 and 5 (dur-
ing infection) significantly different from time points -1
(pre-infection) and 60 (convalescence). Using the Uni-
Frac distance measure to assess changes in microbiota
composition of each individual from its own baseline
also revealed no significant differences between any time
points (Fig. 4).
Individual genera/species
Among the 5 most abundantly identified genera, three
(Streptococcus, Prevotella and Rothia) showed very limited
variation during HRV16 infection (less than 10 % of the
baseline abundance), whereas Veillonella decreased by ap-
proximately 25 % and Haemophilus increased by 75 %.
Paired comparisons using a linear mixed model were
used to assess changes over time within individuals, days -1
and 60 being grouped as baseline non-infection measures,
Fig. 2 Human Rhinovirus Infection. Representation of the total Cold Symptom Scores as assessed by a daily questionnaire [1] as well as viral loads
measured through RT-PCR in nasal lavage fluid and throat swabs of healthy volunteers after nasal inoculation of Human Rhinovirus serotype
16 (HRV-16)
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and days 2 and 5 being grouped as infection measures. No
significant changes were observed between day -1 and day
60 specimens at genus or species level. However, at the
genus level, a significant increase (p < 0.05) in relative abun-
dance of Haemophilus and Neisseria was observed during
infection. Analysis of these genera to species level show
significantly increased Haemophilus parainfluenzae
(p-value = 0.0098) and Neisseria subflava (p-value =
0.012). However, false discovery rate (FDR) correction
for multiple comparisons showed an above threshold
risk of type-I error for all these taxa (FDR = 0.12).
Additionally, the largest fold-change observed was a
1200 % (13-fold) increase in the abundance of the
genus Staphylococcus (p = 0.0749 FDR 0.518), which
only represents 0.2 % of the total sequences identified
(Fig. 5). Analysis to species level shows a weak trend
towards increases in Staphylococcus aureus abundance
(p-value = 0.0856 FDR = 0.245).
The increases in H. parainfluenzae during infection
were observed in all volunteers, while the Neisseria
species increased in 5 of 6 volunteers. Staphylococcus
aureus was only present in four volunteers and in-
creased in three, hence the observed correlation between
HRV16 and Staphylococcus aureus was the weakest
(p-value = 0.0856 FDR = 0.245). Observed changes in
the microbiota composition did not correlate with
viral loads or symptom scores (data not shown).
Discussion
In this study we demonstrate for the first time that in-
fection with HRV16 in otherwise healthy volunteers al-
ters upper respiratory tract microbiota composition.
Although the overall changes are moderate, increases in
relative abundances of the bacterial genera Haemophilus,
Staphylococcus and Neisseria were observed. At a species
level, increases were observed of Haemophilus parain-
fluenzae, Staphylococcus aureus and Neisseria subflava
species. These increases in genera and species during
HRV16 infection were observed in nearly all volunteers
who carried these at baseline and relative abundances
returned to baseline levels after the infection was cleared.
Due to the limited number of study subjects (n = 6) and
the stringent correction for multiple observations, these
changes did not reach statistical significance. Nevertheless,
it is striking that from over one hundred genera detected,
substantial increases are recorded for 2 genera generally
associated with secondary bacterial infections after
HRV16 infection (Heamophilus and Staphylococcus).
These findings suggest that changes in the compos-
ition of resident microbiota per se may play a role in the
Fig. 3 Bacterial Phyla. The distribution (and means ± SEM) of the top four phyla grouped by each time point: (day -1 (circles), day 2 (squares), day
5 (triangles pointing up), day 60 (triangles pointing down). No significant changes from baseline were observed in any of the phyla following
HRV-16 infection (p > 0.05 across time points for all phyla using repeated measures ANOVA)
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development of bacterial super-infections associated
with HRV infection. Our data extend previous findings
by Molyneaux et al., who described similar effects of ex-
perimental rhinovirus infection on the sputum micro-
biota in COPD patients [32] where in particular increases
in Haemophilus sp. and Neisseria sp. were observed. How-
ever, in contrast with our findings, the microbiota of HRV
infected healthy volunteers (i.e. without COPD) from the
study by Molyneaux et al. did not seem to be affected [32]
which may be explained by differences in study design,
e.g. the use of sputum specimens vs. throat swabs. Inter-
estingly, in asymptomatic Aboriginal children the presence
of HRV was significantly associated with the presence of H.
influenzae and M. catarrhalis in nasopharyngeal aspirates
[15]. In a Dutch cohort of otitis-prone children, HRV posi-
tivity was significantly associated with the presence of
Streptococcus pneumoniae and M. catarrhalis in the naso-
pharynx, but not with that of H. influenzae [17]. A later
study in healthy children showed that H. influenzae was
positively associated with the presence of HRV [16].
In vitro studies have demonstrated that infection
with HRV induces changes in our microbiota’s habitat
through augmentation of the adhesion of bacterial
pathogens to the airway epithelium [11–13, 33, 34].
Given the complexity of the upper airway ecosystem it
seems likely that direct viro-bacterial as well as
bacterial-bacterial interactions may also play a role. Al-
though a number of these direct interactions have been
identified, their role during HRV infection remains to
be elucidated [35]. The present new data on culture-
independent classification of bacteria present in the
throat during upper respiratory tract infection contrib-
utes to the understanding of upper respiratory tract
microbial communities during HRV16 infection, and
possible polymicrobial interactions.
Despite the statistical limitations mentioned above the
observed trends occur in nearly all individual and involve
‘usual suspects’ for secondary bacterial infections. As the
available volunteers for our study were relatively young
extrapolation of these findings to other age groups should
be done with caution.
Strengths of our study are the stringent exclusion of
the presence of any other respiratory pathogens and our
culture independent next generation sequencing ap-
proach, allowing sufficient depth to identify even the
rarer species in our samples. However, deeper sequen-
cing might have revealed minor other differences in the
community composition [31]. Furthermore, our study
Fig. 4 Principle component analysis (Unifrac measure). Samples coloured by individual: volunteer 1 (red triangles), volunteer 2 (blue triangles),
volunteer 3 (brown triangles), volunteer 4(green circles), volunteer 5 (purple squares), volunteer 6 (yellow triangles). Generally samples seem to
cluster by individual although there is substantial overlap between individuals. There were no significant changes over time with (weighted
Unifrac significance). There were no significant differences between infected vs non-infected samples (weighted Unifrac significance)
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was underpowered to investigate differences in individ-
ual bacterial species in the upper respiratory tract micro-
biota. Some limitations are inherent to 454 sequencing
of 16S genes in general. They include possible bias intro-
duced by the extraction, amplification and sequencing
methodologies. Finally the number of genomic 16S cop-
ies varies considerably from bacteria to bacteria. Cur-
rently there is insufficient knowledge about exact 16S
copy numbers to correct for this [36].
Although we were able to observe changes within each
volunteer before, during and after HRV16 infection, we
did not include a group of uninfected volunteers. How-
ever since our volunteers functioned as their own con-
trols and the human microbiota during health has been
shown to be relatively stable over time [37] it is likely
that the observed microbiota changes were induced by
HRV16 infection although we cannot exclude the possi-
bility the daily collection of throat swabs itself may have
affected microbiota composition. Our approach reduces
the background noise inherent to human microbiota
studies, which is mainly due to the large differences be-
tween individuals. This way we expect a more precise
detection of relevant changes in the microbiota.
The fact that we used sequential samples allowed us to
use the linear mixed model on non-independent (paired)
samples, which focusses on the response of the variables
of interest (bacterial taxa) during the course of the ex-
periment and minimizes background noise of the high
variability between individuals.
Our findings have clinical relevance and may contribute
to further understanding of the early stages in the devel-
opment of bacterial complications, such as acute otitis
media, sinusitis and pneumonia, following HRV and other
respiratory viral infections [4]. Larger controlled serially
sampled studies in experimental and naturally occurring
HRV infections are warranted to confirm and extend our
current observations. It would be of clinical interest to
investigate whether clinical secondary bacterial infec-
tions after HRV infection are actually preceded by simi-
lar changes in microbiota composition.
Conclusions
In conclusion our study showed HRV16 infection is as-
sociated with strong trends towards increases in the rela-
tive abundances of Haemophilus and Neisseria and a
weaker trend towards increases in the relative abun-
dance of Staphylococcus. Even if the observed changes of
upper respiratory tract microbiota are minor overall,
they may be of great clinical significance and could help
explain why HRV infection predisposes to bacterial otitis
media, sinusitis and pneumonia.
Fig. 5 Changes over Time. Changes in relative abundances over time of the genera Haemophilus, Neisseria, Staphylococus and the bacterial
species H. parainfluenzae, Neisseria subflava and Staphylococcus aureus. Strong trends towards increases in the relative abundance of the bacterial
genera Haemophilus (raw p-value = 0.0041, false discovery rate (FDR) 0.178) and Neisseria (raw p-value = 0.0049, FDR 0.178) were observed, as well
as a weaker trend towards increases of the bacterial genus Staphylococcus (raw p = value 0.0749, FRD 0.518). Analysis on species level revealed
trends toward increases of Haemophilus parainfluenzae (raw p-value = 0.0098 FDR = 0.12), Neisseria subflava (raw p-value = 0.012 FDR = 0.12),
Staphylococcus aureus (raw p-value = 0.0856 FDR = 0.245) during infection. Plots represent mean ± SEM
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